Particle.news
Download on the App Store

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Conflicting reports on GPU scale underscore aggressive positioning in a compute race with Eli Lilly’s NVIDIA-backed lab.

Overview

  • Roche says it added 2,176 Nvidia Blackwell GPUs across the U.S. and Europe, bringing its stated total to about 3,000 and what it calls the industry’s largest deployment.
  • Independent outlets report the company now runs more than 3,500 Blackwell GPUs, creating a public discrepancy with Roche’s press-release figure.
  • Under the expanded pact, Roche plans to use NVIDIA BioNeMo for R&D workflows, Omniverse digital twins for manufacturing, Parabricks for data analysis, and NeMo Guardrails for safer conversational tools.
  • Eli Lilly provides the key comparison point after launching a $1 billion NVIDIA-backed discovery lab and unveiling the LillyPod system powered by roughly 1,016 Blackwell GPUs.
  • Roche links its AI buildout to pipeline acceleration, including four obesity and Type 2 diabetes programs advancing toward pivotal trials, as analysts caution that GPU counts mean little without approved medicines.